LOUISVILLE, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will present and host in-person 1x1 investor meetings at the TD Cowen 44th Annual Health Care Conference, which will be held from March 4-6, 2024. TD Cowen 44th Annual Health Care Conference Presentation Date: Monday, March 4, 2024 Presentation Time: 10:30 AM ET Location: Marriot Copley Place, Boston, ...

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the fourth quarter and year ended December 31, 2023 before the open of trading on Friday, March 1. Biodesix’s management will host a conference call and webcast to discuss its financial results and provide a general business update at 8:30 a.m. Eastern Time on the same day. Listeners can register for the webcast via t ...

Despite the recent economic deceleration, positive factors like a tight labor market and strong consumer spending support a resilient U.S. economy. Goldman Sachs predicts increased state and local government spending, and overall expectations suggest that, while there may be a short slowdown, the U.S. economy is anticipated to remain on a positive trajectory in 2024. This positive forecast makes now the best time to invest in these 3 penny stocks.Penny Stocks: Powerbridge Technologies Co Ltd (PBTS)Source: p ...

Biodesix, Inc. (NASDAQ:BDSX) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper Cowie - Chief Financial Officer Conference Call Participants Dustin Scaringe - William Blair Kyle Mikson - Canaccord Genuity Operator Good day and thank you for standing by. Welcome to the Biodesix Quarter Three 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is be ...

BIODESIX, INC. | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------------------------------------------------------------------------|-----------------|-------|-------|--------|-------|--------------------------------|------------------------|-------|-----------------------------------------| | | Common \nShares | | Stock | Amount | | Additional Paid ‑ In \nCapital | Accumula ted \nDeficit | rs' | Total \nStockholde (Deficit) \nEquity | | Balance ‑ Dece ...

Biodesix, Inc. (NASDAQ:BDSX) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper Cowie - Chief Financial Officer Conference Call Participants Maggie Boeye - William Blair Kyle Mikson - Canaccord Genuity Yuko Oku - Morgan Stanley Operator Good day and thank you for standing by. Welcome to the Biodesix Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-on ...

Operating Expenses Cost of diagnostic testing generally consists of cost of materials, direct labor, including bonuses, employee benefits, share-based compensation, equipment and infrastructure expenses associated with acquiring and processing test samples, including sample accessioning, test performance, quality control analyses, charges to collect and transport samples; curation of test results for physicians; and in some cases, license or royalty fees due to third parties. Costs associated with performin ...

Biodesix, Inc. (NASDAQ:BDSX) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper Cowie - Chief Financial Officer Conference Call Participants Alex Vukasin - Canaccord Genuity Operator Good day, and thank you for standing by and welcome to the Biodesix First Quarter 2023 Earnings Conference Call. At this time all participants are in a listen-only mode. After the speakers presentation there will be ...

(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR Delaware 20-3986492 (State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.) 2970 Wilderness Place, Suite 100 Boulder, Colorado 80301 80301 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (303) 417-0500 Non-accelerated filer If an emerging growth company, indicate ...

Biodesix, Inc. (NASDAQ:BDSX) Q4 2022 Earnings Conference Call March 6, 2023 8:00 AM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper Cowie - Chief Financial Officer Conference Call Participants Kyle Mikson - Canaccord Andrew Brackmann - William Blair Operator Good day, and thank you for standing by. Welcome to the Biodesix Fourth Quarter and Year-End 2022 Earnings Conference Call. At this time all participants are in a listen-only mode. After the ...